Anmeldung zum Cancer Update CCC Vienna Jetzt anmelden!

Pathologie, Zelltherapie und Innovationen in der Diagnostik im Fokus:

Das #CCCVienna bietet einen kompakten Überblick zu indolenten #NonHodgkin-Lymphomen – von Diagnostik bis CAR-T und Radioonkologie.

📍 #Cancer Update CCC Vienna
📆 21.04.2026
ℹ️ 3 DFP

✍️ Zur Anmeldung! ⬇️

Dolf Jansen: Kom in opstand... - Vroege Vogels - BNNVARA Een wetenschappelijk artikel dat jarenlang de basis vormde voor de toelating van glyfosaat blijkt nu, 25 jaar later, te zijn teruggetrokken omdat het niet klopte. "Ik word altijd zeer verontwaardig va...

#Sjoemelwetenschap zorgt ervoor dat #glyfosaat nog steeds toegestaan is in de #EU! Kom in opstand! #stoppesticidesnow #parkinsons #nonhodgkin #planetaryhealth #biodiverdity

Dolf Jansen: Kom in opstand... - Vroege Vogels - BNNVARA www.bnnvara.nl/vroegevogels...

Wetenschappelijk stuk ingetrokken na mogelijke betaling door glyfosaatproducent Mogelijk schreven medewerkers van fabrikant Monsanto mee aan het artikel dat claimt dat het bestrijdingsmiddel glyfosaat niet kankerverwekkend is.

Dus de #EU heeft onlangs 10 jaar langer #glyfosaat #pesticide toegestaan en dat is oa gebaseerd op invloedrijk en nu blijkt #frauduleus artikel. Gaat de @ec.europa.eu deze beslissing nu ook herzien? #PrecautionaryPrinciple #Parkinson #Nonhodgkin #Wetenschapsfraude

nos.nl/artikel/2592...

Jammer dat zijn #EVP vrienden door samenspel van #VonderLeyen en #Bayer voor de komende 10 jaar voor vele duizenden nieuwe #glyphosaat patiënten zorgen met #Parkinson,#ALS en #Nonhodgkin

Low Rates of High-Grade Toxicities Seen With Fresh CAR T-Cell Therapy in R/R NHL | ASH Clinical News | American Society of Hematology

According to data from #EHA2025, GLPG5101, a fresh, stem-like, early memory phenotype CD19-directed #CARTcell therapy, demonstrated a manageable safety profile in patients with R/R #nonHodgkin #lymphoma, producing low rates of high-grade toxicities: ow.ly/OY6Y50WlRBk
#HemeSky #Oncology #MedSky

SOGEYA | Social Genomics Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult (AYA) Survivors of Hodgkin and Non-Hodgkin LymphomaSocial Genomic Mechanisms of Health Disparities among Adolescent and...

Know any young adult survivors of #Hodgkin or #NonHodgkin #Lymphoma who would be interested in sharing some of their experience so that we can all figure out how to make some things better?

Please share this widely.

#AYACSM #youngadult #AYA #oncbsky

aftercancergenomics.org

Representative CD20 staining of spleen and mandibular lymph node sections from animals treated with vehicle or CD20-NKCE-IL2v (0.5 mg/kg). Scale bars: 3 mm

This week in #ScienceImmunology: Olivier Demaria, Eric Vivier, & al. use tetraspecific #NKCell engager (comprising an anti- #NKp46 Ab fragment + #IgG1 #Fc fragment + #IL2 variant + anti- #CD20 Ab) to target #BCell -specific #NonHodgkin #lymphoma (B-NHL) in mouse & NHP models!

bit.ly/SI_adp3720

Oregon Court of Appeals Overturns Monsanto-Bayer Trial Victory, Protects Failure-to-Warn Claims - Beyond Pesticides Daily News Blog Oregon Court of Appeals ruled that FIFRA does not preempt pesticide exposure victims’ state law claims against pesticide manufacturers.

The #Oregon Court of Appeals rules that #FIFRA does NOT preempt #pesticide #exposure victims’ state law claims against #producers, building on judicial precedent protecting the right to use #failuretowarn claims. ⚖️ #glyphosate #nonhodgkin #lymphoma Blog:

ow.ly/T2SW50SKkpk

The behaviour of therapeutic antibodies in immunotherapy | CNRS Non-Hodgkin lymphomas are among the most common cancers affecting almost 1.5 million people globally. They cause uncontrolled proliferation of B lymphocytes, a type of white blood cell, to the detriment of healthy cells. Since the end of the 1990s, immunotherapy had been a frontline treatment using synthetic antibodies to target a protein on the surface of B lymphocytes called CD20. The body’s defences then identify these cells covered in antibodies as pathogens and destroy them.

The Behavior of Therapeutic Antibodies in #Immunotherapy:#cancer #NonHodgkin #lymphomas

cnrs.fr/en/behaviour-t…